2 小时on MSN
Illumina outlines 2026 revenue guidance of $4.5B–$4.6B while advancing clinical growth ...
Q4 2025 Management View CEO Jacob Thaysen announced that Q4 results "exceeded expectations, capped off with 20% growth in our ...
Once a month, we feature a story from Lightspeed’s current issue. This month’s selection is “Death Echoes Overlapping” by ...
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the fourth quarter and fiscal year 2025.
Biocomputing research is testing living neurons for computation as scientists look for energy-efficient alternatives to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果